[1]Lv,Kai;Li,Linhu;Wang,Bo;Liu,Mingliang;Wang,Bin;Shen,Weiyi;Guo,Huiyuan;Lu,Yu[EuropeanJournalofMedicinalChemistry,2017,vol.137,p.117-125]
1019021-64-7
1019021-93-2
1019018-46-2
1159827-76-5
1227268-77-0
129912-15-8
80383-38-6 | 2-(Methylsulfonyl)-3-pyridinamine | AA0053A2 | MFCD09933994
79952-42-4 | Monacolin J | AA0054CK | MFCD09832923
811842-30-5 | 2-Bromo-1-fluoro-4-iodobenzene | AA00558X | MFCD04116322
84324-68-5 | 4-Bromo-N-(pyridin-3-ylmethyl)aniline | AA00565B | MFCD00815404
76981-87-8 | 2-(2-Chloro-acetylamino)-6-methyl-4,5,6,7-tetrahydro-benzo[b]thiophene-3-carboxylic acid ethyl ester | AA005777 | MFCD00782379
82747-56-6 | Cicletanine Hydrochloride | AA0057ZX | MFCD09833605
81555-75-1 | Methyl 2-O-Allyl-3-O-(2',3',4',6'-tetra-O-acetyl-α- D-mannopyranosyl)-α-D-mannopyranoside | AA0058XC | MFCD00037596
7467-35-8 | (1-Methyl-1h-benzimidazol-2-yl)methanol | AA005A3O | MFCD00464051
791625-60-0 | Trans-1-(tert-butoxycarbonyl)-4-(4-chlorophenyl)pyrrolidine-3-carboxylic acid | AA005ASG | MFCD05662438
764708-19-2 | N,2-Dimethoxy-N-methylisonicotinamide | AA005BMA | MFCD13189394